Alanosine

Alanosine
Clinical data


ATC code	None
Identifiers
IUPAC name (S)-2-Amino-3-[hydroxy(nitroso)amino]propanoic acid
CAS Number	5854-93-3^Y
PubChem CID	22128
ChemSpider	20787^Y
UNII	2CNI71214Y
ChEMBL	CHEMBL452715^Y
Chemical and physical data
Formula	C₃H₇N₃O₄
Molar mass	149.1 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(O)[C@@H](N)CN(O)N=O
InChI InChI=1S/C3H7N3O4/c4-2(3(7)8)1-6(10)5-9/h2,10H,1,4H2,(H,7,8)/t2-/m0/s1^Y Key:MLFKVJCWGUZWNV-REOHCLBHSA-N^Y
(verify)

Alanosine (also called SDX-102) is a substance that is being studied for the treatment of pancreatic cancer.^[1] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.

References

↑ Yu J (2001). "Alanosine (UCSD).". Curr Opin Investig Drugs. 2 (11): 1623–30. PMID 11763167.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.